| 1 |
33326171 | GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel-Based Chemotherapy in Ovarian Cancer. | 2021 Mar |
1 |
| 2 |
34509058 | Corrigendum to "Targeting G6PD reverses paclitaxel resistance in ovarian cancer by suppressing GSTP1" [Biochem. Pharmacol. 178 (2020), 114092]. | 2021 Nov |
1 |
| 3 |
32535103 | Targeting G6PD reverses paclitaxel resistance in ovarian cancer by suppressing GSTP1. | 2020 Aug |
3 |
| 4 |
30038720 | GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes. | 2018 Jul 3 |
1 |
| 5 |
22320227 | GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer. | 2012 May |
2 |
| 6 |
22824824 | Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance. | 2012 Sep |
1 |
| 7 |
21711528 | Analysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomics. | 2011 Jun 28 |
1 |
| 8 |
17764884 | Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancers. | 2008 Jul |
7 |